Total Hip Arthroplasty in Patients with Hemophilia: What Do We know?
| Autor: | Mortazavi SJ, Daneshpoor SMM, Shafiei SH |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The archives of bone and joint surgery [Arch Bone Jt Surg] 2023; Vol. 11 (7), pp. 434-440. |
| DOI: | 10.22038/ABJS.2023.58812.291 |
| Abstrakt: | Total hip arthroplasty (THA) is the mainstay therapy for terminally hemophilic arthropathy patients. Hemophilic patients have distinguishing characteristics, including the increased likelihood of bleeding, younger age, restricted pre-operative joint motion, disrupted anatomy, and more post-operative side effects. The present study aimed to assess the THA sequels in hemophilic patients from various perspectives, including indications, challenges, factor replacement post-operative outcomes, and other complications. Competing Interests: None |
| Databáze: | MEDLINE |
| Externí odkaz: |
|